Quest Diagnostics®
Expanding access to SARS-CoV-2 (COVID-19) testing
We recognize that providers like you are facing high demand for office visits due to deferred care and patients’ COVID-19 testing needs. To help you better meet your patients needs for care, we’re expanding access to COVID-19 testing at our Patient Service Centers (PSCs)a so you can spend more time seeing patients for routine and chronic care visits—and less time on COVID-19 testing. 

For patients who are in your office for COVID-19 testing, choose Quest for the collected sample. You’ll get timely, insightful results that can help you and your patients make informed decisions.
COVID-19 testing for mildly symptomaticb patients at Quest PSCsa
Supervised self-collection for molecularc SARS-CoV-2 RNA (COVID-19) Qualitative NAAT (test code 39448) is now available at your local PSCs,a providing timely, accurate results for patients who are asymptomatic or experiencing mild, cold-like symptoms.b

Test ordering:

Patients will need a test order from their healthcare professional for COVID-19 testing

Make an appointment:

Patients can schedule an appointment online. Appointments are strongly encouraged. However, walk-ins may be accommodated based on availability

Where to test:

Nearby Quest Patient Service Centersa

Make COVID-19 testing easier for you and your patients. Order today >

To learn more about how we are delivering convenient and reliable COVID-19 testing services and to connect with your local Quest Diagnostics representative, fill out the form below:

I am interested in:

*Required field

Delivering convenience and accessibility

We’re committed to being where your patients need us to be. Our nationwide footprint and extensive partnerships with health plans are just 2 ways our team is dedicated to ensuring your patients can get a COVID-19 test whenever and wherever they need it—offering greater accessibility and value.

Our Quest Patient Service Centers are located across the country—and close to where your patients live and work

Patients can easily access the free MyQuest® patient portal to get proof of their COVID-19 test result as soon as it is ready

$0 out-of-pocket costs
for insured patients

In-network with 90%
of lives nationwided

Latest information on COVID-19 test pricing

New and improved check-in process at our Patient Service Centers

For patients who need same-day testing, we’re making it simple and convenient to get in and out of our Patient Service Centers for COVID-19 supervised self-collection.a

For patients with appointments:
 little to no wait time

For walk-ins:

  • Select the next available service time for the day from the check-in screen
  • If no same-day appointments are available, or the available times do not meet a patient’s schedule, patients can make an appointment for a different day or join a standby liste in the event of a cancellation or opening in the schedule
  • Standby list order is displayed on digital screens in the waiting room, so patients can easily know where they are in line
  • Patients can also use Quest’s mobile check-in to receive a text alert when it’s their turn

Strong safety procedures in place:

  • Face masks are required for all patients and employees
  • 3-feet distancing during supervised self-collection; 6-feet distancing in waiting room
  • Mobile check-in
  • Text alert options for patients waiting for their appointment outside
Not all testing laboratories are created equal. When you need COVID-19 test results you can trust, you can depend on the unmatched accuracy, reliability, and clarity that comes with our decades of experience and quality and leadership in diagnostics.

Quest offers a “gold standard” for clinical diagnostic detection of SARS-CoV-2 (COVID-19): RT-PCR or TMA1

Our SARS-CoV-2 (COVID-19) molecularc platforms offer some of the lowest levels of detection as listed on the FDA website for authorized tests2
As a worldwide leader in diagnostics, we’ve supported healthcare professionals like you on the front lines of the COVID-19 pandemic since Day 1 with accurate, timely test results, delivering insights to empower informed decisions and take life-saving action.
Our commitment to ensure patients have access to the COVID-19 tests they need for their health—and the health of our communities—remains as strong as ever.
Below are some key resources to help you stay up-to-date with the latest COVID-19 test information from Quest:
a Supervised self-collection is not available in the following states due to state regulations: AK, AL, AZ, CA, DC, DE, HI, KS, KY, LA, ME, MI, MN, MS, MT, ND, OK, OR, RI, UT, VT, WA, and WY. Supervised self-collection may be available only at select Patient Service Centers in all other states. Contact your Quest representative for a list of Patient Service Centers offering supervised self-collection in those states.
b If patients are experiencing severe symptoms such as a high-grade fever of 102 °F or more that has lasted for 48 hours or severe and constant shortness of breath, they will need to consult a healthcare provider and will not be eligible for testing at a Patient Service Center.
c Molecular tests include polymerase chain reaction (PCR) and transcription mediated amplification (TMA) tests.
d This is directional data. It is based on 2020 HealthLeaders membership data of private third-party payers at the Managed Care Organization (MCO) level, as well as Quest internal data. Information is believed to be accurate as of January 1, 2020; however, it is subject to change. Does not include Kaiser Permanente access data.
e Where available. 
COVID-19 testing statements
• The antibody tests and the molecular tests (together “All tests”) have not been FDA cleared or approved;
• All tests have been authorized by FDA under EUAs for use by authorized laboratories;
• The antibody tests have been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens;
• The molecular tests have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses, pathogens; and,
• All tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

References
1. CDC. Nucleic Acid Amplification Tests (NAATs). Updated June 14, 2021. Accessed July 20, 2022. https://www.cdc.gov/coronavirus/2019-ncov/lab/naats.html
2. FDA. SARS-CoV-2 reference panel comparative data. Updated December 07, 2020. Accessed March 25, 2022. https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data

Test codes may vary by location. Please contact your local laboratory for more information.

Image content features models and is intended for illustrative purposes only.
Terms of Use | Privacy Notices | Contact Us | QuestDiagnostics.com | Privacy Shield  | Your Privacy Choices

Quest,Quest Diagnostics,any associated logos,and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2022 Quest Diagnostics Incorporated. All rights reserved.